Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome

By Lindholm Åsa   Bixo Marie   Eliasson Mats   Hudecova Miriam   Arnadottir Ragnheidur   Holte Jan   Poromaa Inger Sundström  

Gynecological Endocrinology, Vol. 26, Iss. 10, 2010-10 ,pp. : 743-748

Informa Healthcare

Access to resources Recommend Favorite

Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy

By Agirbasli Mehmet  

Journal of Thrombosis and Thrombolysis, Vol. 32, Iss. 1, 2011-07 ,pp. : 59-63

Springer Publishing Company

Access to resources Recommend Favorite

Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI

By Erem Cihangir  

Endocrine Journal, Vol. 33, Iss. 3, 2008-06 ,pp. : 270-276

Humana Press, Inc

Access to resources Recommend Favorite

Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients with and without thrombosis

By Eroglu Aydan   Ulu Arzu   Akar Nejat  

Journal of Thrombosis and Thrombolysis, Vol. 22, Iss. 2, 2006-10 ,pp. : 111-112

Springer Publishing Company

Access to resources Recommend Favorite

Molecular Advances in Plasminogen Activator Inhibitor 1 Interaction with Thrombin and Tissue-Type Plasminogen Activator

By Stoop A.   van Meijer M.   Horrevoets A.J.G.   Pannekoek H.  

Trends in Cardiovascular Medicine, Vol. 7, Iss. 2, 1997-02 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite